Titan Pharmaceuticals
TTNP
#10543
Rank
NZ$10.45 M
Marketcap
NZ$7.86
Share price
-3.76%
Change (1 day)
17.97%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.48. In 2023 the company made an earnings per share (EPS) of NZ-$12.63 an increase over its 2022 EPS that were of NZ-$25.89.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.63-51.22%
2022NZ-$25.89-15.61%
2021NZ-$30.68-81.37%
2020NZ-$164.63-77.52%
2019NZ-$732.47-56.32%
2018NZ-$1,677-59.51%
2017NZ-$4,142-371.81%
2016NZ$1,524-144.35%
2015NZ-$3,436300%
2014NZ-$858.92-121.54%
2013NZ$3,988-151.38%
2012NZ-$7,761-11.54%
2011NZ-$8,773188.89%
2010NZ-$3,037-10%
2009NZ-$3,374
2007NZ-$13,835-2.38%
2006NZ-$14,172-39.13%
2005NZ-$23,283-16.87%
2004NZ-$28,007-22.43%
2003NZ-$36,1064.9%
2002NZ-$34,41861.9%
2001NZ-$21,258-13.7%
2000NZ-$24,63365.01%
1999NZ-$14,928-35.87%
1998NZ-$23,279-1824.71%
1997NZ$1,350-102.4%
1996NZ-$56,352

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.98-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.27-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$2.42-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.48-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.43-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.63-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA